<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00854438</url>
  </required_header>
  <id_info>
    <org_study_id>1110</org_study_id>
    <nct_id>NCT00854438</nct_id>
  </id_info>
  <brief_title>Reduction of Adverse Events of Anticholinergic Drugs by Multidisciplinary Medical Reviews in Norwegian Nursing Homes</brief_title>
  <acronym>PRADA</acronym>
  <official_title>Pharmacist-initiated Reduction of Anticholinergic Drug Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South-Eastern Norway Regional Health Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian Directorate of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thesis: Is drug-induced anticholinergic activity additive resulting in a total
      anticholinergic load causing harmful side effects in old, fragile patients? Is it possible to
      reduce the anticholinergic load by multidisciplinary medical review including a pharmacist
      and a physician? The effects of the medical reviews are measured by cognitive tests (MMS and
      CERADS word lists), a measure of mouth dryness, serum levels of anticholinergic activity,
      activity of daily living and neuropsychiatric symptoms.

      Design: A randomized, controlled, single blinded interventional study in Norwegian nursing
      homes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have claimed that drugs showing anticholinergic activity in vitro cause high
      levels of serum anticholinergic activity in vivo that might cause impaired cognitive and
      functional functions in elderly. Pathophysiological changes in Alzheimer`s dementia makes
      these patients particularly vulnerable for anticholinergic cognitive impairments. The
      PRADA-study is the first interventional study evaluating the clinical effects of reducing
      drug-induced anticholinergic load in patients with dementia. This is also the first
      interventional study in the Nordic countries evaluating the clinical effects of clinical
      pharmacy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CERADS word list measuring immediately and delayed recall</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mouth dryness</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADL</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum anticholinergic activity</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CERADS word list recognition</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMSE</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NPI</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Anticholinergic Side Effects</condition>
  <arm_group>
    <arm_group_label>Active treatment arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reduction of anticholinergic drug effects by pharmacist review</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multidisciplinary drug reviews by pharmacist and physician</intervention_name>
    <description>Reduction of anticholinergic drug effects by pharmacist review</description>
    <arm_group_label>Active treatment arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Long-term nursing home patients with none, mild or moderate dementia (evaluated by
             CDR9,using drugs with a total anticholinergic burden that might lead to adverse
             events.

        Exclusion Criteria:

          -  Not able to perform the testes because of physical or psychiatric illnesses.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torgeir B. Wyller, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Ullevaal University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hege Kersten, MScPharm/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ullevaal University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ullevaal University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2009</study_first_submitted>
  <study_first_submitted_qc>March 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2009</study_first_posted>
  <last_update_submitted>June 18, 2015</last_update_submitted>
  <last_update_submitted_qc>June 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Torgeir Bruun Wyller</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>anticholinergic drugs</keyword>
  <keyword>adverse events</keyword>
  <keyword>elderly</keyword>
  <keyword>clinical pharmacist</keyword>
  <keyword>Evaluate the clinical effects of reducing anticholinergic in elderly</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholinergic Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

